The widely used interstitial cystitis drug Elmiron has been linked to life-changing and potentially irreversible vision problems in users, including vision loss and blindness occurring during Elmiron treatment or within one year of discontinuing the drug. Unfortunately, because Elmiron is currently the only oral medication FDA approved to treat the symptoms of interstitial cystitis (IC), thousands of IC sufferers have taken the drug long-term with no indication that it could cause serious eye damage and permanently affect their vision. Former users are now filing Elmiron lawsuits against the manufacturer, alleging that they developed retinal maculopathy and other serious vision problems after taking the interstitial cystitis drug. The Elmiron litigation is still in its early stages, so don’t wait to learn about pursuing compensation for alleged Elmiron injuries. Contact us today to find out if you are eligible to file an Elmiron maculopathy claim against Janssen Pharmaceuticals.
POSSIBLE SYMPTOMS OF ELMIRON-RELATED RETINAL MACULOPATHY
Elmiron, also known as pentosan polysulfate sodium, is a prescription medication manufactured by Janssen Pharmaceuticals and indicated for the treatment of interstitial cystitis, a chronic bladder condition characterized by bladder pressure and bladder pain. Elmiron was approved by the FDA in 1996 and has been widely prescribed to manage the symptoms of this bladder condition, for which there is no cure. However, there is a growing body of scientific evidence suggesting that Elmiron users may be at risk for retinal maculopathy or pigmentary maculopathy, a novel disease of the central part of the retina that can cause blindness. What is being referred to as pentosan polysulfate sodium-associated maculopathy is a vision-threatening eye disease specifically tied to Elmiron.
According to a warning Janssen added to the Elmiron drug label in 2020, there is a risk of retinal maculopathy associated with long-term Elimron use, described by the manufacturer as three years of use or longer. However, the warning indicates that these “retinal pigmentary changes” have also been seen with a shorter duration of use. Research also suggests that patients who experience Elmiron side effects may continue to suffer from these retinal changes even after the drug treatment is discontinued. The following are some examples of vision problems that may occur during or shortly after stopping Elmiron:
A growing number of people who took Elmiron are filing lawsuits in courts across the country, many of which have been consolidated in the U.S. District Court for the District of New Jersey as part of a multidistrict litigation (MDL). An MDL is a large group of lawsuits that make similar claims against one or more defendants, i.e. a drug manufacturer. However, product liability lawsuits in MDLs are still treated as individual claims with unique settlement amounts that vary depending on the circumstances of each case. Each Elmiron lawsuit makes similar claims, alleging that Elmiron is a defective and unreasonably dangerous medication, and that Janssen knew or should have known about the risk of retinal maculopathy associated with short-term or long-term Elmiron use, but failed to warn patients and healthcare providers. Plaintiffs with potential Elmiron claims are seeking compensation from Janssen for medical expenses, lost wages, pain and suffering, disability, loss of quality of life, future medical care, and other losses.
Product liability lawyers nationwide are now reviewing claims by former Elmiron users who have suffered from vision problems after taking the interstitial cystitis drug. And there are many other people who have been misdiagnosed with other more common eye diseases, such as age-related macular degeneration, and have continued taking Elmiron, unaware that the drug could be responsible for their worsening vision problems. If you or a loved one suffered vision loss, blurred vision, vision distortion, or another life-changing vision problem after taking Elmiron, do not hesitate to speak to an Elmiron injury attorney about your legal options. With a knowledgeable Elmiron attorney on your side, you may be able to recover the financial compensation you and your loved ones deserve for the injuries you have sustained. Contact us as soon as possible to discuss your options for legal recourse.
Did you or a loved one suffer vision problems or vision loss after using of the IC and Painful Bladder Symptom treatment Elmiron?
Find out if you qualify for compensation.Find Out More
Consumer Safety Watch offers safety advocate services and attorney referral services for patients throughout the United States including the states of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.
Consumer Safety Watch offers consumer safety advocate services or can help you find an attorney throughout the United States including the following cities: Albuquerque, NM; Arlington, TX; Atlanta, GA; Austin, TX; Baltimore, MD; Boston, MA; Charlotte, NC; Chicago, IL; Cleveland, OH; Colorado Springs, CO; Columbus, OH; Dallas, TX; Denver, CO; Detroit, MI; Fresno, CA; Fort Worth, TX; Indianapolis, IN; Honolulu, HI; Houston, TX; Jacksonville, FL; Kansas City, KS; Kansas City, MO; Las Vegas, NV; Long Beach, CA; Los Angeles, CA; Louisville, KY; Memphis, TN; Mesa, AZ; Miami, FL; Miami, OH; Milwaukee, WI; Minneapolis, MN; Nashville, TN; New York City, NY; Oakland, CA; Oklahoma City, OK; Omaha, NE; Philadelphia, PA; Phoenix, AZ; Pittsburgh, PA; Portland, OR; Sacramento, CA; San Antonio, Tx; San Diego, CA; San Francisco, CA; San Jose, CA; Seattle, WA; St. Louis, MO; Tampa, FL; Tucson, AZ; Tulsa, Virginia Beach, VA; Washington, DC; Wichita, KS.
This website is not affiliated with any pharmaceutical or medical device company or any trademarked product. Results are not guaranteed. This website provides a free matching service and is not responsible for information or services from third party providers. Consumer Safety Watch is not a law firm. Every case is different and services available can vary.